XML 40 R23.htm IDEA: XBRL DOCUMENT v3.25.1
BASIC AND DILUTED NET LOSS PER SHARE
 12 Months Ended
Dec. 31, 2024
Earnings Per Share [Abstract]  
BASIC AND DILUTED NET LOSS PER SHARE

NOTE 11 - BASIC AND DILUTED NET LOSS PER SHARE

 

The basic and diluted net loss per share and weighted average number of shares of common stock used in the calculation of basic and diluted net loss per share were presented in the consolidated statements of comprehensive loss for the years ended December 31, 2024 and 2023.

 

In the calculation of the basic and diluted net loss, the Company included warrants that would be exercised for no or little consideration and are exercisable with no contingencies.

 

Due to the net loss to common shareholders in each of the periods presented above, diluted loss per share was computed without consideration to potentially dilutive instruments as their inclusion would have been anti-dilutive. As of December 31, 2024 and 2023, potentially dilutive securities excluded from the diluted loss per share calculation are as follows:

 

         
  

For the Years Ended

December 31,

 
   2024   2023 
         
Series A warrants October 2022   -    1,022,495 
Warrant to underwriters October 2022   51,125    51,125 
Warrant to underwriters May 2023   32,778    32,778 
Warrant to underwriters May 2023   60,476    60,476 
Warrant to underwriters June 2023   35,088    35,088 
Warrant series C June 2023   -    350,878 
Warrant to underwriters June 2023   31,231    31,231 
Warrant series D June 2023   -    312,309 
Warrant series E January 2024   1,685,682    - 
Warrant to underwriters January 2024   84,284    - 
Warrant series F June 2024   3,133,338    - 
Warrant to underwriters June 2024   

78,333

    - 
Outstanding employee stock options to purchase common stock   2,497,366    2,095,362 

 

 

MICROBOT MEDICAL INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands

(Except share and per share data)